Economic impact of using fesoterodine for the treatment of overactive bladder in vulnerable elderly population in the United States

Qin L1, Luo X2, Zou K H2, Snedecor S J1

Research Type

Clinical

Abstract Category

Overactive Bladder

Abstract 498
Pharmacotherapy for Overactive Bladder
Scientific Podium Short Oral Session 34
Friday 9th October 2015
10:22 - 10:30
515ABC
Overactive Bladder Urgency Urinary Incontinence Mathematical or statistical modelling Outcomes Research Methods
1. Pharmerit International, 2. Pfizer Inc
Presenter
X

Xuemei Luo
Pfizer Inc
Links

Abstract

02/05/2025 09:23:41